» Articles » PMID: 29421277

Epidermal Lipid Composition, Barrier Integrity, and Eczematous Inflammation Are Associated with Skin Microbiome Configuration

Abstract

Background: Genomic approaches have revealed characteristic site specificities of skin bacterial community structures. In addition, in children with atopic dermatitis (AD), characteristic shifts were described at creases and, in particular, during flares, which have been postulated to mirror disturbed skin barrier function, cutaneous inflammation, or both.

Objective: We sought to comprehensively analyze microbial configurations in patients with AD across body sites and to explore the effect of distinct abnormalities of epidermal barrier function.

Methods: The skin microbiome was determined by using bacterial 16S rRNA sequencing at 4 nonlesional body sites, as well as acute and chronic lesions of 10 patients with AD and 10 healthy control subjects matched for age, sex, and filaggrin (FLG) mutation status. Nonlesional sampling sites were characterized for skin physiology parameters, including chromatography-based lipid profiling.

Results: Epidermal lipid composition, in particular levels of long-chain unsaturated free fatty acids, strongly correlated with bacterial composition, in particular Propionibacteria and Corynebacteria abundance. AD displayed a distinct community structure, with increased abundance and altered composition of staphylococcal species across body sites, the strongest loss of diversity and increase in Staphylococcus aureus seen on chronic lesions, and a progressive shift from nonlesional skin to acute and chronic lesions. FLG-deficient skin showed a distinct microbiome composition resembling in part the AD-related pattern.

Conclusion: Epidermal barrier integrity and function affect the skin microbiome composition. AD shows an altered microbial configuration across diverse body sites, which is most pronounced at sites of predilection and AD. Eczematous affection appears to be a more important determinant than body site.

Citing Articles

Crosstalk Between the Skin Environment and Microbial Community in Immune-Related Skin Diseases.

Liu K, Deng S, Zhou Y, Xu B, Zhang Y, Li W Clin Rev Allergy Immunol. 2025; 68(1):16.

PMID: 39954089 DOI: 10.1007/s12016-025-09029-2.


Skin microbiota: pathogenic roles and implications in atopic dermatitis.

Huang C, Zhuo F, Guo Y, Wang S, Zhang K, Li X Front Cell Infect Microbiol. 2025; 14:1518811.

PMID: 39877655 PMC: 11772334. DOI: 10.3389/fcimb.2024.1518811.


Effectiveness of Tralokinumab in Different Phenotypes of Atopic Dermatitis: A Real-World Study.

Tolino E, Ambrosio L, Bernardini N, Proietti I, Skroza N, Potenza C Dermatol Ther (Heidelb). 2025; 15(2):337-350.

PMID: 39862316 PMC: 11832826. DOI: 10.1007/s13555-025-01341-1.


Beneficial effects of ultrafine bubble shower on a mouse model of atopic dermatitis.

Matsumoto A, Imanishi H, Yamanaka-Takaichi M, Hirae M, Tsuruta D, Nakai K Front Immunol. 2025; 15():1483000.

PMID: 39790997 PMC: 11714852. DOI: 10.3389/fimmu.2024.1483000.


TMT-proteomics reveals the therapeutic effects of Lianling decoction against atopic dermatitis through infection.

Zhang L, Fan Z, Li L, Sun Z Heliyon. 2024; 10(19):e38381.

PMID: 39403467 PMC: 11471467. DOI: 10.1016/j.heliyon.2024.e38381.